Please Wait.....
Report
Deep Brain Stimulation Devices-Pipeline Insight and Competitive Landscape, 2022
Medical Pipeline (24 Hours) I 2022-07-01 I 60 Pages I DelveInsight
DelveInsight's, "Deep Brain Stimulation Devices-Pipeline Insight and 2022," report provides comprehensive insights about 20+ companies and 23+ pipeline devices in deep brain stimulation (DBS) devices pipeline landscape. The DBS market is expected to undergo substantial growth in the coming years owning to an increasing prevalence of neurological disorders around the world. The growing aging population is also a major growth factor for DBS devices market as it is more susceptible to neurological disorders like Parkinson's disease, Alzheimer's disease and Epilepsy. Therefore, due to an increase in demand of such devices, huge investment is being made on R&D activities in neurological sector, which is the major reason for an extensive pipeline in this segment.
This reports provides a detailed study of the emerging DBS devices along with competitive landscape to help better understand the emerging DBS devices.
Geography Covered
- Global coverage
Deep Brain Stimulation Devices Overview
Deep Brain Stimulation Devices: Understanding
The deep brain stimulation device is a battery-operated, surgically-implanted device. It is sometimes called a pacemaker for the brain. DBSs are commonly used to treat movement disorders as well as neuropsychiatric disorders. DBS is a therapy that relies on the delivery of mild electrical pulses to specific areas in the brain via an implanted lead connected to a battery-powered pulse generator placed in the patient's upper chest area. A physician is able to vary and control the stimulation delivered through the lead to the brain using an external, hand-held programmer. At present, DBS systems use leads with electrodes that send out electrical current in all direction.
Who needs a deep brain stimulation device?
Patients with the following disorder:
- Dystonia
- Epilepsy
- Essential tremor
- Obsessive-compulsive disorder
- Parkinson's disease
?
Deep Brain Stimulation Devices Competitive Assessment
This segment of the deep brain stimulation devices pipeline report encloses its detailed analysis of various pipeline devices which include product description, licensing and collaboration details and other developmental activities including the latest news and press releases. The report also provides list of major players involved in the pipeline product development.
- Electrode Material
Two types of materials are used in the implementation of the electrodes: Brittle materials (e.g. Silicon) and ductile materials (e.g. metals and flexible polymers).
- Product Application
The DBS devices are used in Parkinson's disease, epilepsy, essential tremor, dystonia and obsessive compulsive disorder.
- Major Players in DBS Devices
There are approx. 20+ key companies which are developing the products for DBS devices.
- directSTIM DBS System: Aleva Neurotherapeutics SA.
Aleva's revolutionary DBS system incorporates directional electrode technology and is designed to be more precise and efficient, with optimized stimulation that will potentially reduce side effects. At present, Aleva is the only emerging technology company to be awarded the CE-Mark for Deep Brain Stimulation.
- Picostim: Bioinduction Ltd
Picostim is in clinical trial phase. It is a miniaturized skull-mounted DBS device which is optimized to generate waveforms needed for stimulation of the subthalamic nucleus (STN) and STN region, employing a unique method of controlling stimulation current. The product undergoing clinical trial and is expected to be completed by 2023. It is a single center, open label, non-randomized design with the primary objective of showing similarity in control of motor symptoms for the Picostim device compared with previously published data for existing DBS devices.
Further product details are provided in the report..
?
Deep Brain Stimulation Devices Competitive Benchmarking
This segment of the reports provides analysis of the pipeline report to give a clear understanding of the comparative analysis.
The analysis is based on
- Brand Positioning of Leading companies
- Application
- Industry Collaborations
Deep Brain Stimulation Devices: Commercialization Activity
This segment of the report provides a detailed list of any commercial activity in the field of deep brain stimulator devices ranging from collaboration, mergers and acquisition, recent breakthrough among others.
Development Activities
- In August, 2020, the new Percept PC Neurostimulator with BrainSense developed by Medtronic was implanted to a patient in Penn State Health Milton S. Hershey Medical Center which become the first hospital in the state to implant a patient with a more personalized treatment for neurological disease
- Medtronic in August 2019 recalled the auto-registration feature of its StealthStation DBS software due to inaccuracies caused by minor patient movements during the auto-registration process when used with NexFrame stereotactic system during a DBS procedure. The problem resulted in 11 reports related to injuries and another 22 related to malfunctions, according to FDA.
Further commercial activities are provided in the report..
Deep Brain Stimulation Devices: Reimbursement
- US
US reimbursement policy, Medicare covers DBS for the treatment of essential tremor and/or Parkinsonian tremor. Medicare only consider DBS devices to be reasonable and necessary if they are Food and Drug Administration (FDA) approved devices devices used in accordance with FDA approved protocols governing Category B Investigational Device Exemption (IDE) DBS clinical trials.
Further information is provided in the report..
?
Report Highlights
- Extensive coverage of the DBS devices under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of DBS devices and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry
- The report consists of in depth analysis of pipeline products based on various parameters
Deep Brain Stimulation Devices Report Insights
- Deep Brain Stimulation Devices - Pipeline Analysis
- Deep Brain Stimulation Devices - Unmet Need
- Deep Brain Stimulation Devices - Market Dynamics
- Deep Brain Stimulation Devices - Future Perspectives and Conclusion
- Deep Brain Stimulation Devices - Analyst Views
Key Questions
- What are significant companies in this segment, their information, analysis, and insights to improve R&D strategies?
- How to identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage?
- What are important and diverse types of DBS devices under development?
- What are market-entry and market expansion strategies in DBS devices?
- What are some of the mergers and acquisitions and to identify major players with the most promising pipeline?
- What is in-depth analysis of the product's current stage of development, territory and estimated launch date?
Key Players
- Adaptive Neuromodulation GmbH
- Adept Neuro SA
- Aleva Neurotherapeutics SA
- Bioinduction Limited
- Boston Scientific Corp
- Brainsway Ltd
- Cleveland Medical Devices Inc
- Cortera Neurotechnologies Inc
- Deep Brain Innovations, LLC
- Enspire DBS Therapy Inc
- Functional Neuromodulation Inc.
- Medtronic plc
- NeuroOne Inc
- Nexeon MedSystems Inc
- Wedge Therapeutics
1. Key Insights
2. Deep Brain Stimulation Devices: Snapshot
3. Deep Brain Stimulation Devices
3.1. Product Overview
3.2. Regulatory Approvals based on Class
3.3. Indications
3.4. Mechanism
4. Deep Brain Stimulation Devices Profiles: Competitive Assessment
4.1. Assessment by Electrode Material
4.2. Assessment by Application
4.2.1. Parkinson's disease
4.2.2. Epilepsy
4.2.3. Essential Tremor
4.2.4. Dystonia
4.2.5. Obsessive Compulsive Disorder
4.3. Assessment by Company
4.3.1. Aleva Neurotherapeutics SA
4.3.1.1. directSTIM DBS System: Aleva Neurotherapeutics SA
4.3.1.1.1. Product Information
4.3.1.1.2. Research and Development
4.3.1.1.3. Patent Details
4.3.1.1.4. Regulatory Milestone
4.3.2. Bioinduction Ltd
4.3.2.1. Picostim: Bioinduction Ltd
4.3.2.1.1. Product Information
4.3.2.1.2. Research and Development
4.3.2.1.3. Patent Details
4.3.2.1.4. Regulatory Milestone
*More Companies and products would be added in the final report
5. Deep Brain Stimulation Devices: Competitive Benchmarking : By Company
5.1. Brand Positioning of Leading companies
5.2. Analysis based on Application
5.3. Analysis based on Industry Collaborations
6. Deep Brain Stimulation Devices - Commercialization Activity
6.1. Collaboration
6.2. Licensing
6.3. Merger and Acquisition
6.4. Recent Breakthroughs
6.5. Literature Studies
6.6. KOL Views
7. Deep Brain Stimulation Devices: Regulatory
7.1. US
7.2. Europe
7.3. Japan
8. Deep Brain Stimulation Devices: Reimbursement
8.1. Case Study - US
8.2. Case Study - Europe
8.3. Case Study -Japan
9. Deep Brain Stimulation Devices: Market Dynamics
9.1. Unmet Needs
9.2. Market Drivers
9.3. Market Barriers
10. DelveInsight's Analytical Perspective
10.1. PEST Analysis
10.2. Future Growth Perspectives
11. Conclusion
12. Appendix
12.1. Research Methodology
12.1.1. Coverage
12.1.2. Secondary Research
13. Bibliography
14. DelveInsight Capabilities
15. Disclaimer
16. About DelveInsight
Table 1 Total Pipeline Products
Table 4 Pipeline Products by Electrode Material
Table 8 Pipeline Products by Application
Table 11 List of Companies
Table 17 Aleva Neurotherapeutics SA Pipeline Products & Ongoing Clinical Trials Overview
Table 20 directSTIM DBS System - Product Status
Table 24 directSTIM DBS System - Product Description
Table 27 Bioinduction Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 30 Picostim - Product Status
Table 32 Picostim - Product Description
Figure 1 List of Pipeline Products
Figure 2 Ongoing Clinical Trial
Figure 3 Ongoing Clinical Trial Pipeline Products by Electrode Material
Figure 4 Ongoing Clinical Trial Pipeline Products by Application
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security